Literature DB >> 27862304

Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.

Claire Mounier-Vehier1, Jacques Amar1, Jean-Marc Boivin1, Thierry Denolle1, Jean-Pierre Fauvel1, Geneviève Plu-Bureau2, Vassilis Tsatsaris3, Jacques Blacher1.   

Abstract

High blood pressure in pregnancy remains, by its complications, the leading cause of morbidity as well as maternal and fetal mortality. The frequency (5-10% of pregnancies) and the potential severity of this disease, for both mother and child, encourage to standardize and to optimize our medical practices. If the short-term complications for the mother and child are well known, long-term ones for the mother are beginning to be better identified. The onset of hypertension during pregnancy disrupts the classic organization of health care and requires the intervention of the general practitioner and/or an obstetrician, a gynecologist, a midwife, a cardiologist, a nephrologist. There is not always a care coordinator, and decisions are sometimes taken with delay. This is what drove the French Society of Hypertension, in partnership with the French National College of Gynecologists-Obstetricians, to develop a consensus proposing easy-to-use guidelines. Educating women and all health professionals to hypertension and its management, in line with current scientific data, is one of the major challenges of this consensus.
© 2016 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  blood pressure measurement; cardiovascular risk; general practitioner; hypertension; preeclampsia; treatment

Mesh:

Substances:

Year:  2016        PMID: 27862304     DOI: 10.1111/fcp.12254

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  3 in total

1.  Outcomes following medical termination versus prolonged pregnancy in women with severe preeclampsia before 26 weeks.

Authors:  Mariana A Carvalho; Lina Bejjani; Rossana P V Francisco; Elizabeth G Patino; Alexandre Vivanti; Fernanda S Batista; Marcelo Zugaib; Frédéric J Mercier; Lisandra S Bernardes; Alexandra Benachi
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

2.  Developing management pathways for hypertensive disorders of pregnancy (HDP) in Indonesian primary care: a study protocol.

Authors:  Fitriana Murriya Ekawati; Sharon Licqurish; Ova Emilia; Jane Gunn; Shaun Brennecke; Phyllis Lau
Journal:  Reprod Health       Date:  2019-02-01       Impact factor: 3.223

Review 3.  The Targeting of Nuclear Factor Kappa B by Drugs Adopted for the Prevention and Treatment of Preeclampsia.

Authors:  Agata Sakowicz
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.